FDA
approval
· 2020-02-14
FDA Approved: VOLTAREN ARTHRITIS PAIN — Supplemental Application (Haleon US Holdings LLC)
Summary
FDA approves a supplemental application for Voltaren Arthritis Pain (diclofenac sodium) by Haleon US Holdings LLC to expand the labeling for arthritis pain reli…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for VOLTAREN ARTHRITIS PAIN (DICLOFENAC SODIUM)